<unk>  is an anthelmintic that is FDA approved for the treatment of fascioliasis in patients 6 years of age and older.   Common adverse reactions include abdominal pain, hyperhidrosis, nausea, decreased appetite, headache, urticaria, diarrhea, vomiting, musculoskeletal chest pain, and pruritus.
Triclabendazole
Flubendazole
Mebendazole
Albendazole
Praziquantel
Artemether
Pyrantel pamoate
Ivermectin 